Lip Neoplasms

Phase 2 trials (4)

• durvalumab
• paclitaxel
• carboplatin
• cisplatin

Organization Involved with Phase 3 Indications (4)

• Astellas
• National Cancer Institute (NCI)
• NRG Oncology
• University of Texas at Houston

Organization Involved with Phase 2 Indications (11)

• Celgene
• AstraZeneca
• Pfizer
• ISA Pharmaceuticals
• Harvard University
• ECOG-ACRIN Cancer Research Group
• Jawaharlal Nehru Medical College
• University of California, San Francisco
• University of North Carolina at Chapel Hill
• Erasmus University Rotterdam
• Klus Pharma Inc.

Organization Involved with Phase 1 Indications (7)

• Eisai
• Millennium Pharmaceuticals
• Merck
• BioMed Valley Discoveries, Inc
• Duke University
• James B. and Lois R. Archer Charitable Foundation
• Gateway for Cancer Research